Potential Interplay of the Gatipotuzumab Epitope TA-MUC1 and Estrogen Receptors in Ovarian Cancer

Anti-tumor efficacy of Gatipotuzumab, a therapeutic antibody targeting Tumor-Associated Mucin-1 (TA-MUC1), in relapsed ovarian cancer (OC) appeared to be rather heterogeneous. Whether adding a second anti-neoplastic drug may augment response towards Gatipotuzumab, has not been elucidated so far. Sin...

Descripción completa

Detalles Bibliográficos
Autores principales: Heublein, Sabine, Page, Sabina, Mayr, Doris, Schmoeckel, Elisa, Trillsch, Fabian, Marmé, Frederik, Mahner, Sven, Jeschke, Udo, Vattai, Aurelia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2019
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6359481/
https://www.ncbi.nlm.nih.gov/pubmed/30642093
http://dx.doi.org/10.3390/ijms20020295

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6359481/
https://www.ncbi.nlm.nih.gov/pubmed/30642093
http://dx.doi.org/10.3390/ijms20020295

Ejemplares similares